What do the public think about genome editing? That’s what we hope to find out through our public dialogue on genome editing which takes place in Stockholm on 8 February. The aim with the public dialogue is to discuss the risks and opportunities of disruptive technologies and identify any concerns the public might have.
This public dialogue is the second of two and will involve engaging with 30 members of the Swedish general public. The aim with the public dialogue is to better understand public opinion on disruptive technologies such as the new genome editing technique CRISPR/Cas9 used in science and research. The two public dialogues will also advise how the ORION partner institutions could communicate new technologies with the public and how to implement the use of open consultations in the research process, in the design of call for fundings and in the policy advice process.
The two public dialogues in Stockholm are organized by the ORION partners VA Public & Science in Stockholm and Babraham Institute in Cambridge in close collaboration with Ipsos MORI UK. Participation in the public dialogue is by invitation only and the selection of the participants will be done through face-to-face interviews. The participants will represent a demographic sample of the geographic area.
For more information please get in touch with Maria Hagardt at VA Public & Science.